Why Vor Biopharma Inc (NASDAQ: VOR) Is Worth Including On Your Watchlist

Vor Biopharma Inc (NASDAQ:VOR)’s traded shares stood at 0.31 million during the last session, with the company’s beta value hitting -0.31. At the close of trading, the stock’s price was $1.19, to imply a decrease of -0.83% or -$0.01 in intraday trading. The VOR share’s 52-week high remains $4.99, putting it -319.33% down since that peak but still an impressive 6.72% since price per share fell to its 52-week low of $1.11. The company has a valuation of $81.23M, with an average of 298.28K shares over the past 3 months.

Vor Biopharma Inc (NASDAQ:VOR) trade information

After registering a -0.83% downside in the last session, Vor Biopharma Inc (VOR) has traded red over the past five days. The stock hit a weekly high of 1.2700, dropping -0.83% in its intraday price action. The 5-day price performance for the stock is -0.83%, and -30.81% over 30 days. With these gigs, the year-to-date price performance is -47.11%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Vor Biopharma Inc (VOR) estimates and forecasts

Looking at statistics comparing Vor Biopharma Inc share performance against respective industry, we note that the company has underperformed competitors. Vor Biopharma Inc (VOR) shares are -49.79% down over the last 6 months, with its year-to-date growth rate lower than industry average at 14.86% against 15.70%.

VOR Dividends

Vor Biopharma Inc has its next earnings report out in July. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Vor Biopharma Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.